Wanlong Tan
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Rheumatology top 5%
- Folate and B Vitamins Research
Papers in
- Surgery 23
- Bladder and Urothelial Cancer Treatments 18
- Urinary and Genital Oncology Studies 7
-
- Epigenetics and DNA Methylation 6
- Co-authors
- Lina Hou (15 shared papers)Deyin Xing (1 shared paper)Dan-Yu Lin (1 shared paper)Yongtong Zhu (13 shared papers)Wei Chen (8 shared papers)Chengyong Lei (8 shared papers)Fēi Li (6 shared papers)Pengliang Chen (4 shared papers)
- Journals
- Oncotarget (3 papers)Gene (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)Clinical & Translational Oncology (2 papers)Urology (2 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Wanlong Tan
90 papers receiving 1.5k citations
Wanlong Tan's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 208
- Rheumatology 159
- Oncology 224
- Surgery 348
- Immunology 154
Countries citing papers authored by Wanlong Tan
This map shows the geographic impact of Wanlong Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanlong Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanlong Tan more than expected).
Fields of papers citing papers by Wanlong Tan
This network shows the impact of papers produced by Wanlong Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanlong Tan. The network helps show where Wanlong Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanlong Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. | 2001 | 202 |
| 2 | Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer Hit paper breakdown → | 2024 | 148 |
| 3 | 2014 | 57 | |
| 4 | The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer. | 2016 | 51 |
| 5 | 2011 | 49 | |
| 6 | 2015 | 46 | |
| 7 | 2012 | 43 | |
| 8 | 2017 | 41 | |
| 9 | 2018 | 38 | |
| 10 | 2013 | 36 | |
| 11 | 2020 | 34 | |
| 12 | 2012 | 33 | |
| 13 | 2013 | 31 | |
| 14 | 2016 | 30 | |
| 15 | Red and processed meat intake and risk of bladder cancer: a meta-analysis. | 2014 | 29 |
| 16 | 2012 | 29 | |
| 17 | Association between dietary patterns and coronary heart disease: a meta-analysis of prospective cohort studies. | 2015 | 28 |
| 18 | 2017 | 27 | |
| 19 | 2014 | 26 | |
| 20 | 2013 | 26 |
About Wanlong Tan
Wanlong Tan is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 92 papers that have together received 1.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (7 papers), Epigenetics and DNA Methylation (6 papers), Nutritional Studies and Diet (6 papers), Renal cell carcinoma treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (208 citations), Rheumatology (159 citations), Oncology (224 citations), Surgery (348 citations) and Immunology (154 citations). Wanlong Tan has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Lina Hou, Deyin Xing, Dan-Yu Lin, Yongtong Zhu, Wei Chen, Chengyong Lei, Fēi Li, Pengliang Chen, Xinji Zhang and Fei Li. Their work appears in journals such as Oncotarget, Gene, Urologic Oncology Seminars and Original Investigations, Clinical & Translational Oncology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.